Interleukin-2

Drug / Medication

A cytokine used to prompt T-cells to eradicate cancer, effective in a subset of patients with high mutagenic burden cancers like melanoma and renal cell cancer.

Mentioned in 3 videos

Videos Mentioning Interleukin-2

181 - Viewing cancer through an evolutionary lens: a radically different approach to treatment

181 - Viewing cancer through an evolutionary lens: a radically different approach to treatment

Peter Attia MD

A 'gen 1 immunotherapy' that showed a 10-20% response rate in melanoma, hinting at the potential for immune-based therapies in adjuvant settings.

177 - The development of cancer immunotherapy and its promise for treating advanced cancers

177 - The development of cancer immunotherapy and its promise for treating advanced cancers

Peter Attia MD

A T-cell growth factor discovered in 1976 that enabled the manipulation of lymphocytes outside the body. Administered in the mid-80s, it caused complete durable regressions in widely metastatic melanoma and renal cancer patients.

202 - Peter on nutrition, disease prevention, and more — looking back on the last 100 episodes

202 - Peter on nutrition, disease prevention, and more — looking back on the last 100 episodes

Peter Attia MD

A cytokine used to prompt T-cells to eradicate cancer, effective in a subset of patients with high mutagenic burden cancers like melanoma and renal cell cancer.